Damaged small intestine repaired with hPSC-derived organoids
Cincinnati Children’s have repaired damaged intestines in a rodent model, moving research efforts closer to clinical trials.
List view / Grid view
Cincinnati Children’s have repaired damaged intestines in a rodent model, moving research efforts closer to clinical trials.
The model enables researchers to expand the number of tumours that they can study, increasing their ability to detect novel interactions.
The expansion of Sino Biological and BioGeometry’s strategic partnership promises to accelerate drug discovery.
This study is the first to demonstrate that NSD2 is foundational to the earliest stage of prostate cancer development.
Microbeads enabled the precise release of signal molecules at any time or location within retinal organoids.
The publicly available Human Endometrial Cell Atlas could progress the development of therapeutics for endometriosis.
The study’s findings could contribute to future therapeutic strategies to prevent chronic kidney disease.
The mRNA vaccine candidate more effectively limited symptoms and disease duration in non-human primates.
Researchers found that HD can impair early brain development through defects associated with mitochondrial dysfunction.
NpG-D-PSMA has shown great potential for targeted alpha therapy to combat prostate cancer.
The findings could aid the design of more stable drugs and improve the understanding of diseases linked to peptide aggregation.
RENAISSANCE can quantify unknown intracellular metabolic states, including metabolic fluxes.
The nucleic acid drug, iSN04, could have applications for pathological angiogenesis involved in atherosclerosis, cancer, and retinopathy.
The humanised antibody, Hv1Lt1, showed promising results in pancreatic cancer mouse models.
This study is first to demonstrate with statistical certainty that human visceral adipose tissue accumulated in the abdominal cavity secretes more extracellular vesicles.